Next Article in Journal
Comment on: Jilkova, Z.M.; et al. “Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges” Cancers 2019, 11, 1554
Next Article in Special Issue
Risk of Inflammatory Bowel Disease in Patients with Chronic Myeloproliferative Neoplasms: A Danish Nationwide Cohort Study
Previous Article in Journal
A Human Organoid Model of Aggressive Hepatoblastoma for Disease Modeling and Drug Testing
Previous Article in Special Issue
Heat Shock Proteins and PD-1/PD-L1 as Potential Therapeutic Targets in Myeloproliferative Neoplasms
 
 
Article

Article Versions Notes

Cancers 2020, 12(9), 2669; https://doi.org/10.3390/cancers12092669
Action Date Notes Link
article xml file uploaded 18 September 2020 13:40 CEST Original file -
article xml uploaded. 18 September 2020 13:40 CEST Update https://www.mdpi.com/2072-6694/12/9/2669/xml
article pdf uploaded. 18 September 2020 13:40 CEST Version of Record https://www.mdpi.com/2072-6694/12/9/2669/pdf
article supplementary file uploaded. 18 September 2020 13:40 CEST - https://www.mdpi.com/2072-6694/12/9/2669#supplementary
article html file updated 18 September 2020 13:41 CEST Original file -
article html file updated 7 October 2020 16:48 CEST Update -
article html file updated 22 July 2022 07:43 CEST Update https://www.mdpi.com/2072-6694/12/9/2669/html
Back to TopTop